Strategic Timing for... Read more...
FĂĽhrungswechsel bei Amgen in Deutschland: Carolina Correa ...
A Vote of Confidence Through Dividend Growth
Der Schwab U.S. Dividend Equity ETF hat seine Portfoliozusammensetzung ...
Strategische Ăśbernahmen als Wachstumstreiber
Defence Therapeutics ernennt Dr. Amie Phinney zur Strategie- ...
Piramal Pharma Solutions aide George Medicines Ă mettre ...
CAR-T Cell Therapy Market to Reach USD 11 142.53 million ...
Piramal Pharma publica su informe de sostenibilidad del ...
12.6% CAGR for Cancer Drugs Market to Reach US$516.15 billion ...
Pediatric Relapsed/Refractory Neuroblastoma Market is on ...
Cosmetic Implants Market to Grow at a Robust CAGR of 9.67% ...
Oncology Drugs Market worth $520 billion by 2033 - Exclusive ...
Piramal Pharma Limited annonce ses résultats consolidés ...
Hyaluronic Acid Raw Material Market is projected to grow ...
Spinal Cord Injury Market Likely to Exhibit Substantial ...
BaseLaunch announces a new partnership with AbbVie. BaseLaunch ...
Dragonfly hat nach der Verabreichung des ersten Patienten ...
Regulatory T-cells Market to Observe Significant Growth ...
Dyspareunia Treatment Market to Hit $1 035.4 million by ...
Piramal Pharma Limited Announces Results for Q4 and FY2025 ...
Dragonfly kĂĽndigt klinische Zusammenarbeit zur Erforschung ...
Dragonfly has Received Milestone Payment Following Dosing ...
iOnctura Strengthens Medical and Commercialization Expertise ...
Traumatic Brain Injury Market to Expand at a CAGR of 10.9% ...
Dragonfly Therapeutics Inc. anuncia una colaboraciĂłn clĂnica ...
Triple-Negative Breast Cancer Market Gearing Up for Impressive ...
Immunotherapy Drugs Market worth $580.6 billion by 2029 ...
Global Bispecific Antibody Therapeutics Contract Manufacturing ...
Aquinnah Pharmaceuticals Advances Oral Small Molecule Program ...
Dragonfly Therapeutics startet Phase 1/1b-Studie seiner ...
Simcere Zaiming and AbbVie Announce Partnership to Develop ...
Wearable Injectors Market Worth $15.1 Billion | MarketsandMarkets™ ...
Mild Cognitive Impairment Market is Predicted to Advance ...
Ichnos Glenmark Innovation and AbbVie Announce Exclusive ...
Bioconjugation Market to Hit USD 10.86 Billion by 2029 with ...
PIRAMAL PHARMA SOLUTIONS COMMEMORATES OPENING OF ITS ADC ...
Muscle Relaxant Drugs Market is expected to generate a revenue ...
Piramal Pharma Limited Announces Consolidated Results for ...
Dry Age-related Macular Degeneration Seven Major Market ...
Dragonfly recibe un pago por hito tras la dosificaciĂłn ...
Regenerative Medicine Market to Reach $37.27 Billion by ...
Dental Soft-Tissue Regeneration Market to Hit USD 0.54 Billion ...
Inherited Retinal Disease Market Size and Share to Grow ...
Autism Spectrum Disorder Therapeutics Market to Grow at ...
From Comfort to Cure: 2024 ASCO Meeting Reveals Groundbreaking ...
Body Contouring Treatments Market to Hit USD 2.58 Billion ...
Pharmaceutical Contract Manufacturing Market worth $319.6 ...
Ovarian Cancer Drugs Market Size expected to reach US$ 4.23 ...
Autoinjectors Market to Hit USD 3.02 Billion by 2030: Growth ...
Rising Number of Studies to Develop Novel Therapies For ...
Piramal Pharma Limited annonce ses résultats pour le quatrième ...
Piramal Pharma Limited annuncia i risultati consolidati ...
PIRAMAL PHARMA SOLUTIONS FEIERT DIE EINWEIHUNG SEINER ADC-PRODUKTIONSERWEITERUNG ...
Piramal Pharma Limited gibt konsolidierte Ergebnisse fĂĽr ...
ANVISA aprova EPKINLY™ primeiro anticorpo biespecĂfico ...
EQS-News: Performance One AG: positive Geschäftsentwicklung ...
Performance One AG: positive Geschäftsentwicklung im ersten ...
New York Schluss: Verluste - Sorgen um Krieg in Nahost nehmen ...
Europa Schluss: Verunsicherte Anleger sorgen fĂĽr Verluste ...
Aktien Europa: Verluste nach Erholung am Vortag - Unsicherheit ...
New York Schluss: Rally nach Zolleinigung
Aktien New York: Rally nach Zolleinigung
New York: Rally nach Zolleinigung
Aktien New York Ausblick: Zolleinigung bringt neuen Schwung ...
ANALYSE-FLASH: HSBC senkt Ziel fĂĽr Bayer auf 20 Euro - ...
TAGESVORSCHAU: Termine am 25. April 2025
TAGESVORSCHAU: Termine am 25. April 2025
Parkinson-Info-Tage 2025: Wissen Bewegung und Gemeinschaft ...
Eckert & Ziegler to Supply Actinium Pharmaceuticals with ...
Eckert & Ziegler beliefert Actinium Pharmaceuticals mit ...
Performance One AG: Strategiewechsel zu einer Holding mit ...
TAGESVORSCHAU: Termine am 31. Januar 2025
TAGESVORSCHAU: Termine am 31. Januar 2025
Ripple Therapeutics kĂĽndigt Kooperations- und Lizenzoptionsvereinbarung ...
GNW-Adhoc: Neuer Bericht der Access to Medicine Foundation ...
Ergebnisse aus einer österreichweiten Neurodermitis-Umfrage: ...
NurExone Biologic zur Präsentation der bahnbrechenden ExoPTEN-Therapie ...
GNW-Adhoc: Neuer Bericht beleuchtet globale Trends und Fortschritte ...
NurExones ExoPTEN wird als Glaukom- (GrĂĽner Star) Behandlung ...
GNW-Adhoc: Antikörper-Wirkstoff-Konjugate verschieben die ...
NurExone stellt revolutionäre Therapie für Rückenmarksverletzungen ...
Newron gibt Geschäftsergebnisse 2023 und Ausblick 2024 ...
NurExone präsentiert neue regulatorische Wege für Exosomen-Therapien ...
TAGESVORSCHAU: Termine am 2. Februar 2024. Wirtschafts- ...
TAGESVORSCHAU: Termine am 2. Februar 2024. Wirtschafts- ...
EQS-Adhoc: HBM Healthcare Investments publiziert Quartalsbericht ...
HBM Healthcare Investments publiziert Quartalsbericht per 31. ...
HBM Healthcare Investments publishes Quarterly Report as ...